Evidence map›Paper›PMID 35980554›Full record

ArticleAnnals of surgical oncology2022

Tumor Growth Rate as a Predictive Marker for Recurrence and Survival After Liver Resection in Patients with Liver Metastases of Uveal Melanoma.

Toulsie Ramtohul, Mohamed Abdul-Baki, Manuel Rodrigues, Nathalie Cassoux, Sophie Gardrat, Khadija Ait Rais, Gaëlle Pierron, Toufik Bouhadiba, Vincent Servois, Pascale Mariani

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Toulsie RamtohulDepartment of Radiology, Institut Curie, Paris, PSL Research University, Paris, France. toulsie.ramtohul@curie.fr.
Mohamed Abdul-BakiDepartment of Radiology, Institut Curie, Paris, PSL Research University, Paris, France.
Manuel RodriguesDepartment of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
Nathalie CassouxDepartment of Ocular Oncology, Institut Curie, PSL Research University, Paris, France.
Sophie GardratINSERM U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Paris, France.
Khadija Ait RaisSomatic Genetic Unit, Department of Genetics, Institut Curie, PSL University, Paris, France.
Gaëlle PierronSomatic Genetic Unit, Department of Genetics, Institut Curie, PSL University, Paris, France.
Toufik BouhadibaDepartment of Surgical Oncology, Institut Curie, PSL Research University, Paris, France.
Vincent ServoisDepartment of Radiology, Institut Curie, Paris, PSL Research University, Paris, France. vincent.servois@curie.fr.
Pascale MarianiDepartment of Surgical Oncology, Institut Curie, PSL Research University, Paris, France.
Université Paris Sciences et Lettres · FRInserm · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical management of liver metastases of uveal melanoma (LMUM) is associated with the best survival rates, especially for patients with a low tumor burden in the liver. The aim was to determine whether the tumor growth rate (TGR

methodsThis retrospective study included 99 patients with LMUM treated with liver resection between November 2007 and November 2020. TGR

resultsDFS and OS had a statistically significant positive linear relationship (Spearman correlation r = 0.68, p < 0.001). A disease-free interval (DFI) > 24 months and a TGR DISCUSSION: The assessment of TGR

Indexed as

Liver NeoplasmsUveal NeoplasmsDisease-Free SurvivalHumansPrognosisRetrospective StudiesSurvival RateUveal Melanoma

Identifiers

PMID35980554
OpenAlexW4292249424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.